AMGEN has announced it will cut
2,400 to 2,900 jobs starting later
this year and continuing to next
year, mostly in the US.
This was 12 to 15% of its global
workforce, Amgen said.
The company made the
announcement as part of its
second quarter results, which also
reported that revenue were up
11% to US$5.2b, with 8% product
sales growth driven by sales of
Enbrel (entanercept) and Kyprolis
(cafilzomib).
CLICK HERE for more.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Jul 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.